Version française

Stago at the Heart of Haemostasis

People dedicated to Health

From medical applications

Complications of heparin treatment

In the absence of any straightforward laboratory tests, the most severe complication, known as type II heparin-induced thrombocytopenia (HIT) has...

From medical applications

STA-Procoag-PPL or making microparticles talk

Midway between plasma haemostasis and cellular haemostasis are microparticles, rich in procoagulant phospholipids. An increase in this procoagulant...

From medical applications

Remaining abreast of changes in biomedical science

Listening to and exchanging ideas with members of the biomedical science community has enabled Stago to develop its expertise in the search for...

From medical applications

Complete industrial autonomy

Achieving a balanced policy with regard to investment in research & development (R&D), technological monitoring and rational acquisitions is a key...


  • Tuesday September 15th, 2015 - 2:00 p.m. (UTC) Wednesday September 16th, 2015 - 7:00 a.m. (UTC)

  • Stago Webinar

All news

Tablets App

android appiPad App

This free educational application in English is the first of its kind and has been developed by an expert in Haemostasis… Stago.

Products & Services

STA®-Liquid Anti-Xa: the solution of choice for UFH, LMWH and Fondaparinux monitoring

Stago offers a comprehensive range for anticoagulant monitoring. The new STA®-Liquid Anti-Xa is a specific, easy to use and reliable test. Fully automated test on STA® line analysers, it is the solution of choice for UFH, LMWH and...

Stago Catalogue

Did you know?

Von Willebrand had first described in 1926 a haemorrhagic familial syndrome, inherited in a dominant manner, in a small ethnic group of Aaland islands, located in the Baltic sea, between Sweden and Finland.

RSS feed | Contact us | Credits and copyrights | Disclaimer | Site map | Cookies